Catherine Stehman-Breen
InvestorVenture Partner at F-Prime Capital Partners
Cambridge
FoundedGeneration Bio
About
Catherine Stehman-Breen is a Venture Partner at F-Prime focused on new company creation, with over 30 years of experience in medicine and biopharmaceuticals. She previously served as CEO of Chroma Medicine, Chief Research and Development Officer at Obsidian Therapeutics, Entrepreneur in Residence at Atlas Venture, and Chief Medical Officer at Sarepta Therapeutics, and held leadership roles at Regeneron and Amgen. She holds an MD from the University of Chicago and an MS in epidemiology from the University of Washington, where she remains an affiliate associate professor in the School of Public Health.
Invests in
Biotech
Deals · 1
Generation BioBoard seat
via F-Prime Capital Partners · filed Mar 2018 · $100.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at F-Prime Capital Partners
Frequently asked questions
- Where does Catherine Stehman-Breen work?
- Catherine Stehman-Breen is Venture Partner at F-Prime Capital Partners.
- What does Catherine Stehman-Breen invest in?
- Catherine Stehman-Breen invests in Biotech.
- What companies did Catherine Stehman-Breen found?
- Catherine Stehman-Breen founded Generation Bio.